| Title | Vaccine |
| Abbreviation | Vaccine |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Immunology and Microbiology (miscellaneous) (Q1); Infectious Diseases (Q1); Molecular Medicine (Q1); Public Health, Environmental and Occupational Health (Q1); Veterinary (miscellaneous) (Q1) |
| h-index | 205 |
| Overall Rank/Ranking | 2151 |
| SCImago Journal Rank (SJR) | 1.493 |
| Impact Score | 5.13 |
| Publisher | Elsevier BV |
| Country | Netherlands |
| ISSN | 0264410X, 18732518 |
| Best Quartile | Q1 |
| Coverage History | 1983-2022 |
Vaccine is a journal covering the technologies/fields/categories related to Immunology and Microbiology (miscellaneous) (Q1); Infectious Diseases (Q1); Molecular Medicine (Q1); Public Health, Environmental and Occupational Health (Q1); Veterinary (miscellaneous) (Q1). It is published by Elsevier BV. The overall rank of Vaccine is 2151. According to SCImago Journal Rank (SJR), this journal is ranked 1.493. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 205. The best quartile for this journal is Q1.
The ISSN of Vaccine journal is 0264410X, 18732518. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Vaccine is cited by a total of 14511 articles during the last 3 years (Preceding 2022).
The impact score (IS) 2022 of Vaccine is 5.13, which is computed in 2023 as per its definition. Vaccine IS is increased by a factor of 1.28 and approximate percentage change is 33.25% when compared to preceding year 2021, which shows a rising trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
IS 2022 of Vaccine is 5.13. If the same upward trend persists, impact score may rise in 2023 as well.
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 5.13 |
| 2021 | 3.85 |
| 2020 | 3.27 |
| 2019 | 3.17 |
| 2018 | 3.17 |
| 2017 | 3.39 |
| 2016 | 3.43 |
| 2015 | 3.53 |
| 2014 | 4.08 |
Vaccine has an h-index of 205. It means 205 articles of this journal have more than 205 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Vaccine is 0264410X, 18732518. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Vaccine is 2151. According to SCImago Journal Rank (SJR), this journal is ranked 1.493. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 1.493 |
| 2021 | 1.392 |
| 2020 | 1.585 |
| 2019 | 1.683 |
| 2018 | 1.759 |
| 2017 | 1.863 |
| 2016 | 1.985 |
| 2015 | 2.073 |
| 2014 | 2.105 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2151 |
| 2021 | 2384 |
| 2020 | 2051 |
| 2019 | 1814 |
| 2018 | 1711 |
| 2017 | 1558 |
| 2016 | 1421 |
| 2015 | 1344 |
| 2014 | 1278 |
Vaccine is published by Elsevier BV. It's publishing house is located in Netherlands. Coverage history of this journal is as following: 1983-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Vaccine is Vaccine. This abbreviation ('Vaccine') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Immunology and Microbiology (miscellaneous) (Q1); Infectious Diseases (Q1); Molecular Medicine (Q1); Public Health, Environmental and Occupational Health (Q1); Veterinary (miscellaneous) (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
The latest impact index of the Vaccine is 5.13. It's evaluated in the year 2022. The highest and the lowest impact index or impact score of this journal are 5.13 (2022) and 3.17 (2019), respectively, in the last 9 years. Moreover, its average IS is 3.67 in the previous 9 years.
The Vaccine has an SJR (SCImago Journal Rank) of 1.493, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 2.105 in 2014 and the lowest being 1.392 in 2021. Furthermore, the average SJR of the Vaccine over the previous 9-year period stands at 3.67.
The latest h-index of the Vaccine is 205.
The Vaccine is published by the Elsevier BV, with its country of publication being the Netherlands.
The Vaccine is currently ranked 2151 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 1278 in 2014 and its lowest position of 2384 in 2021.
The standard ISO4 abbreviation for the Vaccine is Vaccine.
Vaccine is classified as a journal that the Elsevier BV publishes.
The Vaccine encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Vaccine is assigned the following International Standard Serial Numbers (ISSN): 0264410X, 18732518.
The best quartile for the Vaccine is Q1 (2022).
The Vaccine coverage history can be summarized as follows: 1983-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Proceedings of the ASME Turbo Expo | conference and proceedings | 17577 | 54 | 0.00 | |
| Journal of International Financial Management and Accounting | journal | 6179 | Wiley-Blackwell Publishing Ltd | 42 | 6.09 |
| Mathematical Modelling and Analysis | journal | 11315 | Vilnius Gediminas Technical University | 27 | 1.75 |
| Child and Family Social Work | journal | 8628 | Wiley-Blackwell Publishing Ltd | 67 | 2.20 |
| International Journal of Parallel, Emergent and Distributed Systems | journal | 15843 | Taylor and Francis Ltd. | 23 | 1.28 |
| International Journal of Research and Method in Education | journal | 5180 | Taylor and Francis Ltd. | 34 | 2.49 |
| Sex Education | journal | 5168 | Routledge | 41 | 2.82 |
| Transnational Corporations | journal | 6120 | UNCTAD United Nations Conference on Trade and Development | 27 | 1.92 |
| Studies in Continuing Education | journal | 6011 | Routledge | 38 | 2.81 |
| Libyan Studies | journal | 16122 | Cambridge University Press | 8 | 0.45 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 5.13 |
| 2021 | 3.85 |
| 2020 | 3.27 |
| 2019 | 3.17 |
| 2018 | 3.17 |
| 2017 | 3.39 |
| 2016 | 3.43 |
| 2015 | 3.53 |
| 2014 | 4.08 |
5.13
205
2151
1.493
